| Podcast
Medical and recreational marijuana are sources of great confusion to patients and clinicians alike. A culture of “neuromysticism” around medical marijuana has arisen, leaving patients and clinicians muddled regarding what constitutes “medical” marijuana. This is due in part to the poor quality of...
| Article
Newswise — Millennials lead the escalating interest in marijuana and cannabinoid compounds for managing pain – with older generations not far behind – and yet most are unaware of potential risks. Three-quarters (75%) of Americans who expressed interest in using marijuana or cannabinoids to address...
| Article
Newswise — Marijuana increased in popularity in the mid-1970s when there was interest in cannabinoids for reduction in intraocular pressure (IOP), which is the fluid pressure inside the eye. Now, its usage has increased due to its pleasure-inducing side effects, and behind tobacco, alcohol and...
| Article
As has been frequently noted by different contributors to the PAINWeek platform, there is a range of opinion on the safety and efficacy of medical cannabis, brought on in no small part by the dearth of clinical study resulting from current federal regulatory status. New research from the University...
| Article
A research team composed of members from China, Russia, and the US have announced a significant advance in understanding the structure of CB2, one of 2 cannabinoid receptors in the human endocannabinoid system. Cannabinoid receptors can be targeted to address a range of pathological conditions...
| Article
An article and accompanying editorial published this month in the Canadian Journal of Cardiology reinforces other warnings concerning the adverse cardiovascular effects of medical cannabis, especially in older patients. The authors relate the case of a 70-year-old male patient with chronic pain and...